Zacks Research Analysts Raise Earnings Estimates for NOVONIX

NOVONIX Limited Sponsored ADR (NASDAQ:NVX) – Equities research analysts at Zacks Research increased their FY2026 earnings per share (EPS) estimates for shares of NOVONIX in a research note issued to investors on Thursday, September 3rd. Zacks Research analyst M. Marin now anticipates that the company will post earnings of ($2.70) per share for the year, up from their prior estimate of ($4.90). The consensus estimate for NOVONIX’s current full-year earnings is ($4.90) per share.

Separately, Weiss Ratings downgraded shares of NOVONIX from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

NOVONIX Price Performance

NASDAQ NVX opened at $2.74 on Thursday. The business has a fifty day simple moving average of $3.99 and a 200 day simple moving average of $5.96. NOVONIX has a 12 month low of $2.65 and a 12 month high of $38.60. The company has a debt-to-equity ratio of 0.20, a current ratio of 0.97 and a quick ratio of 0.97.

NOVONIX (NASDAQ:NVX) last posted its earnings results on Friday, July 31st. The company reported ($0.06) earnings per share for the quarter.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Jane Street Group LLC bought a new stake in shares of NOVONIX during the 4th quarter worth $1,063,000. XTX Topco Ltd raised its position in NOVONIX by 388.0% in the fourth quarter. XTX Topco Ltd now owns 270,796 shares of the company’s stock worth $274,000 after acquiring an additional 215,305 shares during the period. SmartHarvest Portfolios LLC purchased a new position in NOVONIX in the first quarter valued at about $100,000. Citadel Advisors LLC boosted its stake in NOVONIX by 964.1% in the third quarter. Citadel Advisors LLC now owns 109,374 shares of the company’s stock valued at $140,000 after acquiring an additional 99,095 shares during the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in shares of NOVONIX during the 4th quarter worth approximately $97,000. Institutional investors own 0.06% of the company’s stock.

NOVONIX Company Profile

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company’s primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.